This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Io Therapeutics, Inc.
Drug Names(s): IRX4310
Description: IRX4310 is a pan-RAR antagonist which stimulates granulopoiesis. Studies in murine models have shown that IRX4310 promotes recovery of neutrophils. Additionally the studies indicated protection against live bacterial challenge-induced lethality in cyclophosphamide-treated neutropenic mice.
Additional information available to subscribers only: